A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine

Get answers to your Genitourinary cancer questions.
Dr. Heather Mannuel’s Bio | Q&A Archive
Prostate-specific antigen; Prostate cancer screening test
No certain PSA level that is called normal or abnormal. No PSA level means you do or do not have prostate cancer. Remember that the PSA test cannot diagnose cancer. Only a biopsy can diagnose cancer. Always discuss PSA test results with your doctor
Your doctor will look at your PSA results and must consider your age, your race, medicines you are taking, and a number of other factors to decide whether your PSA is normal and whether you need more tests done.
Older men typically have slightly higher PSA levels than younger men. Normal ranges by age group commonly used include:
Normal value ranges may vary slightly among different laboratories. Talk to your doctor about the meaning of your specific test results.
A high PSA level has been linked to an increased chance of having prostate cancer. However, a high PSA level only identifies patients at higher risk of having prostate cancer.
As a general guideline, the following results indicate a need for further follow-up and testing:
Keep in mind that, although PSA testing is an important tool for detecting prostate cancer, it is not foolproof. Your doctor must also think about other factors besides cancer that may cause higher PSA values:
Your doctor will think about the following factors when deciding on the next step:
People at higher risk may need to have more tests. Next steps your doctor may take include:
For someone who has been treated for prostate cancer, the PSA level can show if a treatment is working or if the cancer has come back. Often, PSA levels will begin to rise before there are any symptoms, sometimes months or years beforehand.
American Urological Association.
Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force. Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:192-199.
Lim LS, Sherin K; ACPM Prevention Practice Committee. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Am J Prev Med. 2008;34:164-170.
Walsh PC, DeWeese TL, Eisenberger MA. Clinical practice. Localized prostate cancer. N Engl J Med. 2007;357:2696-2705.
Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296:2336-2342.
Wolf AM, Wender RC, Etzioni RB, Thompson IM, D'Amico AV, Volk RJ, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60:70-98.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885